• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941824500
Medical Device Problem Codes Difficult to Remove (1528); Failure to Advance (2524); Defective Device (2588); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/18/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that difficulty removal were encountered.The target lesion was located in the right coronary artery (rca).A 5.00 x 24mm synergy xd drug eluting stent was selected for use.The synergy xd drug eluting stent was advanced but could not cross the lesion.Upon removal the synergy xd drug eluting stent, the stent was catching on the catheter.It was observed that the balloon was slightly inflated on each end of the stent.The procedure was completed with a non-bsc stent.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy xd mr ous 5.00 x 24 mm stent delivery system was returned for analysis.Examination of the crimped stent via scope found no issues with the stent.There were no signs of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal marker bands.The crimped stent outer diameter was measured by snap gauge and the result was within max crimped stent profile measurement.The balloon cones were reviewed via scope, and no issues were noted.The balloon wings were tightly wrapped and evenly folded.The balloon had not been subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube shaft found multiple kinks along several locations of the hypotube shaft.The shaft polymer extrusion including the distal and mid-shaft sections were examined via scope and tactile examination.No issues were noted.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that difficulty removal were encountered.The target lesion was located in the right coronary artery (rca).A 5.00 x 24mm synergy xd drug eluting stent was selected for use.The synergy xd drug eluting stent was advanced but could not cross the lesion.Upon removal the synergy xd drug eluting stent, the stent was catching on the catheter.It was observed that the balloon was slightly inflated on each end of the stent.The procedure was completed with a non-bsc stent.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11474135
Report Number2134265-2021-02712
Device Sequence Number14422141
Product Code NIQ
UDI-Device Identifier08714729981275
UDI-Public08714729981275
Combination Product (Y/N)Y
Initial Reporter StateNM
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/11/2022
Device Model NumberH7493941824500
Device Lot Number0026382640
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/01/2021
Initial Date Received by Manufacturer 02/18/2021
Supplement Date Received by Manufacturer04/28/2021
Initial Report FDA Received Date03/12/2021
Supplement Report FDA Received Date05/12/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age56 YR
-
-